Killer antibodies enter clinical trial against ovarian cancer.
Kerkvliet
G J
GJ
D000230:Adenocarcinoma / Q000628:therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000628:therapy*; D011868:Radioisotopes / Q000627:therapeutic use*; D012211:Rhenium / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D011868:Radioisotopes; D012211:Rhenium